A compromised intrauterine environment that delivers low levels of oxygen and/or nutrients, or is infected or inflammatory, can result in fetal brain injury, abnormal brain development and in cases of chronic compromise, intrauterine growth restriction. Preterm birth can also be associated with injury to the developing brain and affect the normal trajectory of brain growth. This review will focus on the effects that episodes of perinatal hypoxia (acute, chronic, associated with inflammation or as an antecedent of preterm birth) can have on the developing brain. In animal models of these conditions we have found that relatively brief (acute) periods of fetal hypoxemia can have significant effects on the fetal brain, for example death of susceptible neuronal populations (cerebellum, hippocampus, cortex) and cerebral white matter damage. Chronic placental insufficiency which includes fetal hypoxemia, nutrient restriction and altered endocrine status can result in fetal growth restriction and long-term deficits in neural connectivity in addition to altered postnatal function, for example in the auditory and visual systems. Maternal/fetal inflammation can result in fetal brain damage, particularly but not exclusively in the white matter; injury is more pronounced when associated with fetal hypoxemia. In the baboon, in which the normal trajectory of growth is affected by preterm birth, there is a direct correlation between a higher flux in oxygen saturation and a greater extent of neuropathological damage. Currently, the only established therapy for neonatal encephalopathy in full term neonates is moderate hypothermia although this only offers some protection to moderately but not severely affected brains. There is no accepted therapy for injured preterm brains. Consequently the search for more efficacious treatments continues; we discuss neuroprotective agents (erythropoietin, N-acetyl cysteine, melatonin, creatine, neurosteroids) which we have trialed in appropriate animal models. The possibility of combining hypothermia with such agents or growth factors is now being considered. A deeper understanding of causal pathways in brain injury is essential for the development of efficacious strategies for neuroprotection.
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Introduction
During fetal life the developing brain is vulnerable to many factors, which together with genetic makeup, can contribute to a spectrum of functional and behavioural disorders that manifest throughout life. Protecting the brain from injury during the fetal, peripartum and neonatal periods is of major importance owing to the significant number of infants who now survive very preterm birth but develop neurodevelopmental and motor disabilities. Up Abbreviations: BDNF, brain derived neurotrophic factor; FIRS, fetal inflammatory response syndrome; IUGR, intrauterine growth restriction; IL, interleukin; LPS, lipopolysaccharide; NMDA, n-methyl-d-aspartate; OL, oligodendrocyte; ROS, reactive oxygen species; rhEPO, recombinant erythropoietin; TNF, tumour necrosis factor; VLBW, very low birth weight.
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to 10% of infants who survive very preterm birth will develop spastic motor deficits such as cerebral palsy (Holling and Leviton, 1999; Platt et al., 2007) and a further 25-50% will suffer cognitive, behavioural, attentional and socialisation deficits (Allin et al., 2008; Larroque et al., 2008; Woodward et al., 2005) . Hypoxic-ischemic encephalopathy in term neonates can also result in a range of motor and neurodevelopmental disabilities (Azzopardi et al., 2009; Gluckman et al., 2005; Shankaran et al., 2005) . Currently, the only established therapy for neonatal encephalopathy in infants born at term is hypothermia and, although this has been confirmed as significant in reducing death and disability at 18 months (Edwards et al., 2010; Zhou et al., 2010) , its ability to provide protection to the developing nervous system is far from complete. Further animal experimentation is required to elucidate the mechanisms underlying the etiology of perinatal brain injury to improve outcomes. Studies of the brain of both humans and experimental animals following intrauterine insults show that the nature of the fetal neuropathology depends on the nature and severity of the
